Stephen E Zale

USPTO Granted Patents = 50 (Patent Applications = 25)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 4.0

ph-index = 27

Forward Citations = 2,431(Granted Patents)

Forward Citations (Not Self Cited) = 2,205(Oct 12, 2025)

Location History:

Hopkington, MA (US) (1997 - 1999)
Hopkinton, MA (US) (2002 - 2024)

Company Filing History:

20 out of 27

Bind Therapeutics, Inc.

patents

9 out of 12

Bind Biosciences, Inc.

Alkermes Controlled Therapeutics, Inc.

patents

5. 3 out of 9

Lyndra Therapeutics, Inc.

patents

6. 2 out of 8,369

Massachusetts Institute of Technology

patents

7. 2 out of 1,370

The Brigham and Women's Hospital, Inc.

Alkermes Controlled Therapeutics, Inc. I

patent

10. 1 out of 1

Alkermas Controlled Therapeutics, Inc.

patent

11. 1 out of 160

Alkermes Pharma Ireland Limited

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109305 - Materials architecture for gastric residence systems (2024-10-08),

2. 12023406 - Gastric residence systems with release rate-modulating films (2024-07-02),

3. 11576866 - Gastric residence systems for sustained delivery of adamantane-class drugs (2023-02-14),

4. 10137088 - Therapeutic nanoparticles having EGFR ligands and methods of making and using same (2018-11-27),

5. 10071056 - Cancer cell targeting using nanoparticles (2018-09-11),

6. 9872848 - Stable formulations for lyophilizing therapeutic particles (2018-01-23),

7. 9835572 - Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers (2017-12-05),

8. 9579386 - Drug loaded polymeric nanoparticles and methods of making and using same (2017-02-28),

9. 9579284 - Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same (2017-02-28),

10. 9498443 - Stable formulations for lyophilizing therapeutic particles (2016-11-22),

11. 9393310 - Drug loaded polymeric nanoparticles and methods of making and using same (2016-07-19),

12. 9351933 - Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same (2016-05-31),

13. 9308179 - Long circulating nanoparticles for sustained release of therapeutic agents (2016-04-12),

14. 9295727 - Cancer cell targeting using nanoparticles (2016-03-29),

15. 9198874 - Long circulating nanoparticles for sustained release of therapeutic agents (2015-12-01),

Title: The Innovative Journey of Stephen E Zale

Introduction: Stephen E Zale, a talented inventor hailing from Hopkinton, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Stephen E Zale's latest patents include cutting-edge advancements in the fields of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Stephen E Zale has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous projects that have revolutionized their respective industries.

Collaborations: Throughout his career, Stephen E Zale has collaborated with top-notch engineers, scientists, and researchers, fostering a culture of innovation and excellence that has resulted in the successful development of groundbreaking technologies.

Conclusion: Stephen E Zale's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor whose work continues to shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.